Orion Oyj

Latest Results (27.12.2024):

Net Sales Growth

Orion Oyj's net sales for the first half of 2024 increased by 12.2% to EUR 636.7 million, compared to EUR 567.5 million in the same period of 2023. This growth was primarily driven by the strong performance of Nubeqa®, the Easyhaler® product portfolio, and the Animal Health business division. Exchange rate fluctuations contributed a positive impact of EUR 2.3 million to the net sales.

Operating Profit Increase

For the first half of 2024, Orion Oyj reported an operating profit of EUR 121.8 million, marking a 19.5% increase from EUR 102.0 million in the previous year. The growth in operating profit was largely attributed to the increase in net sales and the significant contribution from Nubeqa® royalties, despite a planned rise in operating expenses.

Profit for the Period

Orion Oyj's profit for the first half of 2024 rose by 42.7% to EUR 52.0 million, up from EUR 36.4 million in the same period of 2023. Basic earnings per share also saw an increase, reaching EUR 0.68 compared to EUR 0.57 in the previous year.

Cash Flow Improvement

The cash flow from operating activities per share for Orion Oyj in the first half of 2024 was EUR 0.98, a significant improvement from EUR 0.27 in the same period of 2023. This increase reflects the company's enhanced operational efficiency and financial performance during the period.

Upgraded Financial Outlook

Following the strong performance in the first half of 2024, Orion Oyj upgraded its financial outlook for the year. The company now estimates net sales to be between EUR 1,440 million and EUR 1,480 million, with an operating profit projected to range from EUR 350 million to EUR 380 million. This is an increase from the previous estimates of EUR 1,340 million to EUR 1,410 million for net sales and EUR 280 million to EUR 310 million for operating profit.